Cardiac resynchronization therapy optimization using cardiac activation sequence information

• US 8,725,255 B2
• Filed: 11/17/2006
• Issued: 05/13/2014
• Est. Priority Date: 11/17/2006
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Arcot-Krishnamurthy, Shantha, Zhang, Yi, Ding, Jiang, Yu, Yinghong, Dong, Yanting
• Primary Examiner(s): Porter, Jr., Allen
• Application Number:
  US11/601,216
• Publication Number:
  US 20080119903A1
• Time in Patent Office: 2,734 Days
• Field of Search: 607/2, 607/4, 607/5, 607/7, 607/9, 607/10, 607/11, 607/17, 607/15, 607/27, 600508-522
• US Class Current: 607/9
• CPC Class Codes: A61B 5/341 Vectorcardiography [VCG]
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/353 Detecting P-waves
• CPC Class Codes: A61B 5/358 Detecting ST segments
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/36535 controlled by body position or posture
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration

Abstract

Systems and methods provide for pacing a heart to improve pumping efficiency of the heart, such as by producing a cardiac fusion response for patient'"'"'s subject to cardiac resynchronization therapy. A pacing parameter, such as an A-V delay, V-V delay, lead/electrode configuration or vector, is adjusted and a cardiac signal vector representative of all or a portion of one or more cardiac activation sequences is monitored during pacing parameter adjustment. A change in a characteristic of the cardiac signal vector is detected in response to an adjusted pacing parameter, the change indicative of a cardiac fusion response. A pacing therapy may be delivered to produce the cardiac fusion response using the adjusted pacing parameter.

Claims

1. A system, comprising:

a plurality of electrodes configured for at least sensing cardiac electrical activity and energy delivery;

a signal processor coupled to the electrodes and configured to produce a cardiac signal vector on a polar plot that originates at an atrioventricular (AV) node of a subject'"'"'s heart, the cardiac signal vector associated with all or a portion of one or more cardiac activation sequences; and

a controller coupled to the electrodes and the signal processor, the controller configured to;

adjust a pacing parameter to elicit a cardiac signal vector indicative of one of pacing-dominant cardiac activation and intrinsic-dominant cardiac activation,

continue to adjust the pacing parameter to elicit a cardiac signal vector indicative of the other of the pacing-dominant cardiac activation and the intrinsic-dominant cardiac activation,

detect a change in an axis angle or a magnitude of the cardiac signal vector in response to the adjustment of the pacing parameter,

define the change in the axis angle or the magnitude of the cardiac signal vector as a transition between the pacing-dominant cardiac activation and intrinsic-dominant cardiac activation; and

store the adjusted pacing parameters to define a transition region.

2. The system of claim 1, wherein the controller is configured to iteratively adjust the pacing parameter until a pacing parameter setting that produces a cardiac fusion response is identified.

3. The system of claim 1, wherein the controller is disposed within an implantable housing, a patient-external housing, or distributed in both the implantable and patient-external housing.

4. The system of claim 1, wherein the signal processor is disposed within an implantable housing, a patient-external housing, or distributed in both the implantable and patient-external housing.

5. The system of claim 1, wherein the plurality of electrodes comprise implantable electrodes, cutaneous electrodes, or a combination of implantable and cutaneous electrodes.

6. The system of claim 1, further comprising an implantable housing, wherein the controller and the signal processor are provided in the housing, and the electrodes comprise implantable electrodes coupled to, or provided on, the housing.

7. The system of claim 1, further comprising a patient-external housing, wherein the controller and the signal processor are provided in the housing, and the electrodes comprise cutaneous electrodes coupled to the housing.

8. The system of claim 1, wherein the pacing parameter comprises A-V delay.

9. The system of claim 1, wherein the controller is coupled to memory, the memory configured to store a look-up table comprising pacing parameters associated with one or both of heart rate and patient condition, the pacing parameters established to produce a cardiac fusion pacing response.

10. The system of claim 9, wherein the controller is configured to update the look-up table with updated pacing parameters in response to identification of a change in the cardiac signal vector characteristic being indicative of pacing-dominant cardiac activation or intrinsic-dominant cardiac activation, the updated pacing parameters established to produce the cardiac fusion pacing response for the patient.

11. The system of claim 9, wherein the controller, in response to identification of a change in the cardiac signal vector being indicative of a change in intrinsic-dominant cardiac activation, is configured to update the look-up table with updated baselines characterizing each of the patient'"'"'s intrinsic-dominant cardiac activation and pacing-dominant cardiac activation responses.

12. A system, comprising:

a plurality of electrodes configured for at least sensing cardiac electrical activity and energy delivery;

a signal processor coupled to the electrodes and configured to produce a cardiac signal vector on a polar plot that originates at an atrioventricular (AV) node of a subject'"'"'s heart, the cardiac signal vector associated with all or a portion of one or more cardiac activation sequences; and

a controller coupled to memory, the electrodes, and the signal processor, the controller configured to;

adjust a pacing parameter to elicit a cardiac signal vector indicative of one of pacing-dominant cardiac activation and intrinsic-dominant cardiac activation,

continue to adjust the pacing parameter settings to elicit a cardiac signal vector indicative of the other of the pacing-dominant cardiac activation and the intrinsic-dominant cardiac activation pacing responses,

detect a change in an axis angle or a magnitude of the cardiac signal vector in response to the adjustment of the pacing parameter;

define a change above a predetermined threshold value in the axis angle or the magnitude of the cardiac signal vector as a transition between the pacing-dominant cardiac activation and the intrinsic-dominant cardiac activation,

store at least one adjusted pacing parameter setting in the memory to record the transition between the pacing-dominant cardiac activation and the intrinsic-dominant cardiac activation responses, and

deliver a pacing therapy that uses the stored pacing parameter setting.

13. The system of claim 12, wherein the controller is disposed within an implantable housing, a patient-external housing, or distributed in both the implantable and patient-external housing.

14. The system of claim 12, wherein the signal processor is disposed within an implantable housing, a patient-external housing, or distributed in both the implantable and patient-external housing.

15. The system of claim 12, wherein the plurality of electrodes comprise implantable electrodes, cutaneous electrodes, or a combination of implantable and cutaneous electrodes.

16. The system of claim 12, further comprising an implantable housing, wherein the controller and the signal processor are provided in the housing, and the electrodes comprise implantable electrodes coupled to, or provided on, the housing.

17. The system of claim 12, further comprising a patient-external housing, wherein the controller and the signal processor are provided in the housing, and the electrodes comprise cutaneous electrodes coupled to the housing.

18. The system of claim 12, wherein the controller is configured to iteratively adjust the pacing parameter until the pacing parameter setting that produces a cardiac fusion response is identified.

19. The system of claim 12, wherein the controller is configured to store a look-up table in the memory, the look-up table comprising pacing parameters associated with one or both of heart rate and patient condition, the pacing parameters comprising the pacing parameter setting established to produce a cardiac fusion response.

20. The system of claim 19, wherein the controller is configured to update the look-up table with updated pacing parameters in response to a change in the cardiac signal vector characteristic indicative of pacing-dominant cardiac activation or intrinsic-dominant cardiac activation, the updated pacing parameters comprising the pacing parameter setting established to produce the cardiac fusion response.

21. The system of claim 19, wherein the controller, in response to a change in the cardiac signal vector characteristic indicative of a change in intrinsic-dominated cardiac activation, is configured to update the look-up table with updated baselines characterizing each of the patient'"'"'s intrinsic-dominated cardiac activation and pacing-dominant cardiac activation responses.